Elanco schedules November 6 results for Elanco Animal Health stock
Published on 10/27/2026 at 20:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting date November 6, 2026
- Elanco scheduled its third-quarter earnings call for November 6, 2026.
- Second-quarter revenue rose 10.20 percent to USD 1.368 billion.
- Elanco Animal Health stock costs EUR 20.41 at Lang & Schwarz on October 27, 2026 at 8:17 p.m. CET, minus 0.10 percent versus the Xetra close of October 27, 2026 at EUR 20.43.
- Elanco's market capitalization was USD 11.3 billion as of October 27, 2026.
Elanco Animal Health (US28414H1032) has set November 6, 2026 for its third-quarter earnings call, according to the company's Investor Relations page. At Lang & Schwarz, the stock was trading at EUR 20.41 on October 27, 2026 at 8:17 p.m. CET, minus 0.10 percent versus the Xetra close of October 27, 2026 at EUR 20.43.
November 6 is the next date
The November event gives investors the next scheduled checkpoint after Elanco's second-quarter performance. The company lists the event as its third-quarter 2026 earnings call, starting at 8:00 a.m. EST on November 6, 2026, on its investor calendar.
Second-quarter growth reached 10.20 percent
Elanco reported USD 1.368 billion in revenue for the second quarter ended June 30, 2026, an increase of 10.20 percent from the year-earlier period, according to the Benzinga transcript. Adjusted gross margin reached 58.10 percent in the quarter, up 80 basis points from the same period a year earlier.
NYSE valuation sets the frame
On the NYSE, Elanco stock last traded at USD 22.65 on October 27, 2026 at 3:20 p.m. ET, down 1.35 percent from the prior close. Its market capitalization was USD 11.3 billion, while the 52-week range stood at USD 19.40 to USD 27.98 on the same date.
The second-quarter update also included full-year 2026 guidance of USD 5.09 billion to USD 5.14 billion in revenue and adjusted earnings per share of USD 1.10 to USD 1.16. The scheduled November 6 call will provide the next company update on those ranges and on third-quarter execution.
Price stays close to the Xetra close
The small euro-market gap keeps the German trading perspective nearly unchanged after the Xetra session. The Lang & Schwarz price was EUR 0.02 below the Xetra close, equivalent to minus 0.10 percent after the Xetra close.
Elanco develops animal-health products for companion animals and livestock. Its business spans vaccines, parasiticides, antibiotics and nutritional products, giving the November reporting date relevance for both pet-health demand and farm-animal sales.
The further course of trading is shown by the continuously updated real-time quote of Elanco Animal Health stock.
Elanco Animal Health at a glance
- Company: Elanco Animal Health Incorporated
- ISIN: US28414H1032
- Ticker: ELAN
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 27, 2026 at 8:17 p.m. CET): EUR 20.41
- Change versus Xetra close: minus 0.10 percent
- Xetra close (October 27, 2026): EUR 20.43
- Market capitalization: USD 11.3 billion (as of October 27, 2026)
- 52-week range: USD 19.40-27.98 (as of October 27, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
Market context: Market report S&P 500.
